Understanding Risk in the COVID-19 Era
Study Examines Tofacitinib’s Long-Term Cardiovascular Risk & More
Systemic Sclerosis Patients May Benefit from Targeted Stroke Screening
Increased Risk of Inflammatory Arthritis with Hidradenitis Suppurativa
Risk Assessment & Treatment in APS Patients
Galectin-3 May Be a Biomarker for Cardiovascular Disease in RA
Rheumatoid Arthritis Risk Lower Among Smokers Who Quit
History of Depression Is a Risk Factor for SLE in Women
Walking Ability of OA Patients Linked to Cardiovascular Risk
- 1
- 2
- 3
- …
- 8
- Next Page »